HCV-RNA kinetics on-treatment do not predict sustained virologic response in HCV genotype 3 patients receiving sofosbuvir and ribavirin

J Hepatol. 2016 Nov;65(5):1058-1059. doi: 10.1016/j.jhep.2016.06.031. Epub 2016 Jul 25.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents
  • Drug Therapy, Combination
  • Genotype
  • Hepacivirus / genetics
  • Hepatitis C
  • Hepatitis C, Chronic
  • Humans
  • Kinetics
  • RNA
  • RNA, Viral
  • Ribavirin*
  • Sofosbuvir*
  • Sustained Virologic Response

Substances

  • Antiviral Agents
  • RNA, Viral
  • Ribavirin
  • RNA
  • Sofosbuvir